Transition states, analogues, and drug development

ACS Chemical Biology

Volumn 8, Issue 1, 2013, Pages 71-81

  Schramm, Vern L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; FORODESINE; INDINAVIR; MENAQUINONE; NUCLEOSIDASE; PURINE NUCLEOSIDE PHOSPHORYLASE; RIBOSOME INACTIVATING PROTEIN;

CONFORMATIONAL TRANSITION; DRUG DEVELOPMENT; DRUG STRUCTURE; GEOMETRY; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW;

DRUG DESIGN; ENZYMES; HIV PROTEASE; HIV PROTEASE INHIBITORS; INDINAVIR; KINETICS; MODELS, BIOLOGICAL; MODELS, MOLECULAR;

EID: 84872556816     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300631k     Document Type: Review

References (94)

1. Wolfenden, R. (1999) Conformational aspects of inhibitor design: enzyme-substrate interactions in the transition state Bioorg. Med. Chem. 7, 647-652 (Pubitemid 29238061)
2. Schramm, V. L. (2011) Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes Annu. Rev. Biochem. 80, 703-732
3. Saen-Oon, S., Quaytman-Machleder, S., Schramm, V. L., and Schwartz, S. D. (2008) Atomic detail of chemical transformation at the transition state of an enzymatic reaction Proc. Natl. Acad. Sci. U.S.A. 105, 16543-16548
4. Schwartz, S. D. and Schramm, V. L. (2009) Enzymatic transition states and dynamic motion in barrier crossing Nat. Chem. Biol. 5, 551-558
5. Hirschi, J. S., Arora, K., Brooks, C. L., 3rd, and Schramm, V. L. (2010) Conformational dynamics in human purine nucleoside phosphorylase with reactants and transition-state analogues J. Phys. Chem. B 114, 16263-16272
6. Zewail, A. H. (2000) Femtochemistry: Atomic-scale dynamics of the chemical bond using ultrafast lasers (Nobel Lecture) Angew. Chem., Int. Ed. 39, 2586-2631 (Pubitemid 30629182)
7. Dantus, M., Bowman, R. M., Baskin, J. S., and Zewail, A. H. (1989) Femtosecond real-time alignment in chemical reactions Chem. Phys. Lett. 159, 406-412
8. Pedersen, S., Bañares, L., and Zewail, A. H. (1992) Femtosecond vibrational transition-state dynamics in a chemical reaction J. Chem. Phys. 97, 8801-8804
9. Polanyi, J. C. and Zewail, A. H. (1995) Direct observation of the transition state Acc. Chem. Res. 28, 119-132
10. Bolhuis, P. G., Chandler, D., Dellago, C., and Geissler, P. L. (2002) Transition path sampling: throwing ropes over rough mountain passes in the dark Annu. Rev. Phys. Chem. 53, 291-318
11. Dellago, C., Bolhuis, P. G., and Chandler, D. (1998) Efficient transition path sampling: application to Lennard-Jones cluster rearrangements J. Chem. Phys. 108, 9236-9245 (Pubitemid 128571335)
12. Basner, J. E. and Schwartz, S. D. (2005) How enzyme dynamics helps catalyze a chemical reaction in atomic detail: a transition path sampling study J. Am. Chem. Soc. 127, 13822-13831 (Pubitemid 41437032)
13. Antoniou, D. and Schwartz, S. D. (2011) Protein dynamics and enzymatic chemical barrier passage J. Phys. Chem. B 115, 15147-15158
14. Nagel, Z. D. and Klinman, J. P. (2009) A 21st century revisionist's view at a turning point in enzymology Nat. Chem. Biol. 5, 543-550
15. Hur, S. and Bruice, T. C. (2003) Just a near attack conformer for catalysis (chorismate to prephenate rearrangements in water, antibody, enzymes, and their mutants) J. Am. Chem. Soc. 125, 10540-10542 (Pubitemid 37055905)
16. Wolfenden, R. (2011) Benchmark reaction rates, the stability of biological molecules in water, and the evolution of catalytic power in enzymes Annu. Rev. Biochem. 80, 645-667
17. Silva, R. G., Murkin, A. S., and Schramm, V. L. (2011) Femtosecond dynamics coupled to chemical barrier crossing in a Born-Oppenheimer enzyme Proc. Natl. Acad. Sci. U.S.A. 108, 18661-18665
18. Kipp, D. R., Silva, R. G., and Schramm, V. L. (2011) Mass-dependent bond vibrational dynamics influence catalysis by HIV-1 protease J. Am. Chem. Soc. 133, 19358-19361
19. Shen, C. H., Tie, Y., Yu, X., Wang, Y. F., Kovalevsky, A. Y., Harrison, R. W., and Weber, I. T. (2012) Capturing the reaction pathway in near-atomic-resolution crystal structures of HIV-1 protease Biochemistry 51, 7726-7732
20. Kipp, D. R., Hirschi, J. S., Wakata, A., Goldstein, H., and Schramm, V. L. (2012) Transition states of native and drug-resistant HIV-1 protease are the same Proc. Natl. Acad. Sci. U.S.A. 109, 6543-6548
21. Cleland, W. W. (1995) Isotope effects: determination of enzyme transition state structure Methods Enzymol. 249, 341-373
22. Wolfenden, R. (1976) Transition state analog inhibitors and enzyme catalysis Annu. Rev. Biophys. Bioeng. 5, 271-306
23. Wolfenden, R. (1969) Transition state analogues for enzyme catalysis Nature 223, 704-705
24. Gandour, R. D. and Schowen, R. L. (1978) Transition States of Biochemical Processes, Plenum Press, New York.
25. Cleland, W. W., O'Leary, M. H., and Northrop, D. B. (1977) Isotope effects on enzyme-catalyzed reactions, In Proceedings of the Sixth Annual Harry Steenbock Symposium, University Park Press, Baltimore.
26. Schramm, V. L. (1999) Enzymatic transition-sate analysis and transition-state analogs Methods Enzymol. 308, 301-355 (Pubitemid 29418909)
27. Mahalingam, A. K., Axelsson, L., Ekegren, J. K., Wannberg, J., Kihlström, J., Unge, T., Wallberg, H., Samuelsson, B., Larhed, M., and Hallberg, A. (2010) HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells J. Med. Chem. 53, 607-615
28. Pauling, L. (1948) Chemical achievement and hope for the future Am. Sci. 36, 51-58
29. Fedorov, A., Shi, W., Kicska, G., Fedorov, E., Tyler, P. C., Furneaux, R. H., Hanson, J. C., Gainsford, G. J., Larese, J. Z., Schramm, V. L., and Almo, S. C. (2001) Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis Biochemistry 40, 853-860 (Pubitemid 32108576)
30. Schramm, V. L. and Shi, W. (2001) Atomic motion in enzymatic reaction coordinates Curr. Opin. Struct. Biol. 11, 657-665 (Pubitemid 34076625)
31. Ferrer, S., Ruiz-Pernía, J., Martí, S., Moliner, V., Tuñón, I., Bertrán, J., and Andrés., J. (2011) Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives Adv. Protein Chem. Struct. Biol. 85, 81-142
32. Exequiel, J. R., Pineda, T., Antoniou, D., and Schwartz, S. D. (2010) Slow conformational motions that favor sub-picosecond motions important for catalysis J. Phys. Chem. B 114, 15985-15990
33. Garcia-Viloca, M., Gao, J., Karplus, M., and Truhlar, D. G. (2004) How enzymes work: analysis by modern rate theory and computer simulations Science 303, 186-195 (Pubitemid 38057561)
34. Sawa, T., Fukagawa, Y., Homma, I., Takeuchi, T., and Umezawa, H. (1967) Mode of inhibition of coformycin on adenosine deaminase J. Antibiot. (Tokyo) 20, 227-231
35. Cha, S., Agarwal, R. P., and Parks, R. E., Jr. (1975) Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin Biochem. Pharmacol. 24, 2187-2197
36. Guan, R., Ho, M. C., Fröhlich, R. F., Tyler, P. C., Almo, S. C., and Schramm, V. L. (2012) Methylthioadenosine deaminase in an alternative quorum sensing pathway in Pseudomonas aeruginosa Biochemistry 51, 9094-9103
37. Thomas, K., Haapalainen, A. M., Burgos, E. S., Evans, G. B., Tyler, P. C., Gulab, S., Guan, R., and Schramm, V. L. (2012) Femtomolar inhibitors bind to 5′-methylthioadenosine nucleosidases with favorable enthalpy and entropy Biochemistry 51, 7541-7550
38. Wang, S., Haapalainen, A. M., Yan, F., Du, Q., Tyler, P. C., Evans, G. B., Rinaldo-Matthis, A., Brown, R. L., Norris, G. E., Almo, S. C., and Schramm, V. L. (2012) A picomolar transition state analogue inhibitor of MTAN as a specific antibiotic for Helicobacter pylori Biochemistry 51, 6892-6894
39. Clinch, K., Evans, G. B., Fröhlich, R. F., Gulab, S. A., Gutierrez, J. A., Mason, J. M., Schramm, V. L., Tyler, P. C., and Woolhouse, A. D. (2012) Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics Bioorg. Med. Chem. 20, 5181-5187
40. Parkin, D. W. and Schramm, V. L. (1984) Effects of allosteric activation on the primary and secondary kinetic isotope effects for three AMP nucleosidases J. Biol. Chem. 259, 9418-25 (Pubitemid 14060500)
41. Mentch, F., Parkin, D. W., and Schramm, V. L. (1987) Transition-state structures for N-glycoside hydrolysis of AMP by acid and by AMP nucleosidase in the presence and absence of allosteric activator Biochemistry 26, 921-930 (Pubitemid 17021074)
42. Parkin, D. W. and Schramm, V. L. (1987) Catalytic and allosteric mechanism of AMP nucleosidase from primary, beta-secondary, and multiple heavy atom kinetic isotope effects Biochemistry 26, 913-920 (Pubitemid 17021073)
43. max mutant of AMP nucleosidase by the application of heavy-atom kinetic isotope effects Biochemistry 30, 4586-4594
44. Ehrlich, J. I. and Schramm, V. L. (1994) Electrostatic potential surface analysis of the transition state for AMP nucleosidase and for formycin 5′-phosphate, a transition-state inhibitor Biochemistry 33, 8890-8896 (Pubitemid 24257996)
45. Hurwitz, J., Heppel, L. A., and Horecker, B. L. (1957) The enzymatic cleavage of adenylic acid to adenine and ribose 5-phosphate J. Biol. Chem. 226, 525-540
46. McCann, J. A. and Berti, P. J. (2007) Transition state analysis of acid-catalyzed dAMP hydrolysis J. Am. Chem. Soc. 129, 7055-7064 (Pubitemid 46903270)
47. Schramm, V. L. (1976) Comparison of initial velocity and binding data for allosteric adenosine monophosphate nucleosidase J. Biol. Chem. 251, 3417-3424
48. DeWolf, W. E., Jr., Fullin, F. A., and Schramm, V. L. (1979) The catalytic site of AMP nucleosidase. Substrate specificity and pH effects with AMP and formycin 5′-PO4 J. Biol. Chem. 254, 10868-10875 (Pubitemid 10159382)
49. Zhang, Y., Cottet, S. E., and Ealick, S. E. (2004) Structure of Escherichia coli AMP nucleosidase reveals similarity to nucleoside phosphorylases Structure 12, 1383-1394 (Pubitemid 39092083)
50. Leung, H,B. and Schramm, V. L. (1980) Adenylate degradation in Escherichia coli. The role of AMP nucleosidase and properties of the purified enzyme J. Biol. Chem. 255, 10867-10874 (Pubitemid 11171742)
51. Morrison, B. A. and Shain, D. H. (2008) An AMP nucleosidase gene knockout in Escherichia coli elevates intracellular ATP levels and increases cold tolerance Biol. Lett. 4, 53-56 (Pubitemid 351598296)
52. Parry, B. R. and Shain, D. H. (2011) Manipulations of AMP metabolic genes increase growth rate and cold tolerance in Escherichia coli: implications for psychrophilic evolution Mol. Biol. Evol. 28, 2139-2145
53. Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R., and Diamond, L. K. (1975) Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity Lancet 1, 1010-1013
54. Cohen, A., Doyle, D., Martin, D. W., Jr., and Ammann, A. J. (1976) Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase New Engl. J. Med. 295, 1449-1454 (Pubitemid 8003705)
55. Cohen, A., Gudas, L. J., Ammann, A. J., Staal, G. E., and Martin, D. W., Jr. (1978) Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency J. Clin. Invest. 61, 1405-1409
56. Morris, P. E., and Omura, G. A. (2000) Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis Curr. Pharm. Des. 6, 943-959 (Pubitemid 30409391)
57. Kline, P. C. and Schramm, V. L. (1993) Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction Biochemistry 32, 13212-13219 (Pubitemid 24005930)
58. Miles, R. W., Tyler, P. C., Furneaux, R. H., Bagdassarian, C. K., and Schramm, V. L. (1998) One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase Biochemistry 37, 8615-8621 (Pubitemid 28299598)
59. Balakrishnan, K., Verma, D., O'Brien, S., Kilpatrick, J. M., Chen, Y., Tyler, B. F., Bickel, S., Bantia, S., Keating, M. J., Kantarjian, H., Gandhi, V., and Ravandi, F. (2010) Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia Blood 116, 886-892
60. Homminga, I., Zwaan, C. M., Manz, C. Y., Parker, C., Bantia, S., Smits, W. K., Higginbotham, F., Pieters, R., and Meijerink, J. P. (2011) In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia Blood 118, 2184-2190
61. Lewandowicz, A. and Schramm, V. L. (2004) Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases Biochemistry 43, 1458-1468 (Pubitemid 38200551)
62. Evans, G. B., Furneaux, R. H., Lewandowicz, A., Schramm, V. L., and Tyler, P. C. (2003) Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase J. Med. Chem. 46, 5271-5276 (Pubitemid 37414195)
63. Bantia, S., Harman, L., Hollister, A., and Pearson, P. (2012) BCX4208, a novel enzyme inhibitor for chronic management of gout shows a low risk of potential drug-drug interactions. Presented at the Annual European Congress of Rheumatology (EULAR); 2012 June 6-9; Berlin, Germany. Abstract.
64. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Schramm, V. L., and Kim, K. (2002) Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase J. Biol. Chem. 277, 3226-3231 (Pubitemid 34953185)
65. Luo, M., Singh, V., Taylor, E. A., and Schramm, V. L. (2007) Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases J. Am. Chem. Soc. 129, 8008-8017 (Pubitemid 46998200)
66. Cassera, M. B., Hazleton, K. Z., Merino, E. F., Obaldia, N., 3rd, Ho, M. C., Murkin, A. S., DePinto, R., Gutierrez, J. A., Almo, S. C., Evans, G. B., Babu, Y. S., and Schramm, V. L. (2011) Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model PLoS One 6, e26916
67. Singh, V. and Schramm, V. L. (2006) Transition-state structure of human 5′-methylthioadenosine phosphorylase J. Am. Chem. Soc. 128, 14691-14696 (Pubitemid 44749872)
68. Evans, G. B., Furneaux, R. H., Schramm, V. L., Singh, V., and Tyler, P. C. (2004) Targeting the polyamine pathway with transition-state analogue inhibitors of 5′-methylthioadenosine phosphorylase J. Med. Chem. 47, 3275-3281 (Pubitemid 38702720)
69. Basu, I., Cordovano, G., Das, I., Belbin, T. J., Guha, C., and Schramm, V. L. (2007) A transition state analogue of 5′-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers J. Biol. Chem. 282, 21477-21486 (Pubitemid 47099931)
70. Basu, I., Locker, J., Cassera, M. B., Belbin, T. J., Merino, E. F., Dong, X., Hemeon, I., Evans, G. B., Guha, C., and Schramm, V. L. (2011) Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5′-methylthioadenosine phosphorylase J. Biol. Chem. 286, 4902-4911
71. Wahome, P. G., Robertus, J. D., and Mantis, N. J. (2012) Small-molecule inhibitors of ricin and Shiga toxins Curr. Top. Microbiol. Immunol. 357, 179-207
72. Chen, X.-Y., Berti, P. J., and Schramm, V. L. (2000) Transition state analysis for depurination of DNA by Ricin A-chain J. Am. Chem. Soc. 122, 6527-6534 (Pubitemid 30489970)
73. Sturm, M. B., Roday, S., and Schramm, V. L. (2007) Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design J. Am. Chem. Soc. 129, 5544-5550 (Pubitemid 46697642)
74. Sturm, M. B., Tyler, P. C., Evans, G. B., and Schramm, V. L. (2009) Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein Biochemistry 48, 9941-9948
75. Ho, M. C., Sturm, M. B., Almo, S. C., and Schramm, V. L. (2009) Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins Proc. Natl. Acad. Sci. U.S.A. 106, 20276-20281
76. Nealson, K., Platt, T., and Hastings, J. W. (1970) The cellular control of the synthesis and activity of the bacterial luminescent system J. Bacteriol. 104, 313-322
77. Kepseu, W. D., Van Gijsegem, F., and Sepulchre, J. A. (2012) Modelling the onset of virulence in pathogenic bacteria Methods Mol. Biol. 804, 501-517
78. Choi, J., Shin, D., Kim, M., Park, J., Lim, S., and Ryu, S. (2012) LsrR-mediated quorum sensing controls invasiveness of Salmonella typhimurium by regulating SPI-1 and flagella genes PLoS One 7, e37059
79. Liang, H., Deng, X., Ji, Q., Sun, F., Shen, T., and He, C. (2012) The Pseudomonas aeruginosa global regulator VqsR directly inhibits QscR to control quorum-sensing and virulence gene expression J. Bacteriol. 194, 3098-3108
80. Ulrich, R. L., Deshazer, D., Brueggemann, E. E., Hines, H. B., Oyston, P. C., and Jeddeloh, J. A. (2004) Role of quorum sensing in the pathogenicity of Burkholderia pseudomallei J. Med. Microbiol. 53, 1053-1064 (Pubitemid 40052485)
81. Gutierrez, J. A., Crowder, T., Rinaldo-Matthis, A., Ho, M. C., Almo, S. C., and Schramm, V. L. (2009) Transition state analogs of 5′- methylthioadenosine nucleosidase disrupt quorum sensing Nat. Chem. Biol. 5, 251-257
82. Singh, V., Lee, J. E., Núñez, S., Howell, P. L., and Schramm, V. L. (2005) Transition state structure of 5′- methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli and its similarity to transition state analogues Biochemistry 44, 11647-11659 (Pubitemid 41262698)
83. Singh, V. and Schramm, V. L. (2007) Transition-state analysis of S. pneumoniae 5′-methylthioadenosine nucleosidase J. Am. Chem. Soc. 129, 2783-2795 (Pubitemid 46417953)
84. Singh, V., Luo, M., Brown, R. L., Norris, G. E., and Schramm, V. L. (2007) Transition-state structure of Neisseria meningitides 5′- methylthioadenosine/S-adenosylhomocysteine nucleosidase J. Am. Chem. Soc. 129, 13831-13833 (Pubitemid 350106071)
85. Gutierrez, J. A., Luo, M., Singh, V., Li, L., Brown, R. L., Norris, G. E., Evans, G. B., Furneaux, R. H., Tyler, P. C., Painter, G. F., Lenz, D. H., and Schramm, V. L. (2007) Picomolar inhibitors as transition-state probes of 5′-methylthioadenosine nucleosidases ACS Chem. Biol. 2, 725-734 (Pubitemid 350285908)
86. Singh, V., Evans, G. B., Lenz, D. H., Mason, J. M., Clinch, K., Mee, S., Painter, G. F., Tyler, P. C., Furneaux, R. H., Lee, J. E., Howell, P. L., and Schramm, V. L. (2005) Femtomolar transition state analogue inhibitors of 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli J. Biol. Chem. 280, 18265-18273 (Pubitemid 41389072)
87. Li, X., Apel, D., Gaynor, E. C., and Tanner, M. E. (2011) 5′-methylthioadenosine nucleosidase is implicated in playing a key role in a modified futalosine pathway for menaquinone biosynthesis in Campylobacter jejuni J. Biol. Chem. 286, 19392-19398
88. Hiratsuka, T., Furihata, K., Ishikawa, J., Yamashita, H., Itoh, N., Seto, H., and Dairi, T. (2008) An alternative menaquinone biosynthetic pathway operating in microorganisms Science 321, 1670-1673
89. Dairi, T. (2012) Menaquinone biosyntheses in microorganisms Methods Enzymol. 515, 107-22
90. Wang, S., Haapalainen, A. M., Yan, F., Du, Q., Tyler, P. C., Evans, G. B., Rinaldo-Matthis, A., Brown, R. L., Norris, G. E., Almo, S. C., and Schramm, V. L. (2012) A picomolar transition state analogue inhibitor of MTAN as a specific antibiotic for Helicobacter pylori Biochemistry 51, 6892-6894
91. Schwartz, P. A., Vetticatt, M. J., and Schramm, V. L. (2011) Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase Biochemistry 50, 1412-1420
92. Schwartz, P. A., Vetticatt, M. J., and Schramm, V. L. (2010) Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase J. Am. Chem. Soc. 132, 13425-13433
93. Norman, R. A., Barry, S. T., Bate, M., Breed, J., Colls, J. G., Ernill, R. J., Luke, R. W., Minshull, C. A., McAlister, M. S., McCall, E. J., McMiken, H. H., Paterson, D. S., Timms, D., Tucker, J. A., and Pauptit, R. A. (2004) Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor Science 12, 75-84 (Pubitemid 38120276)
94. Zhou, G. C., Parikh, S. L., Tyler, P. C., Evans, G. B., Furneaux, R. H., Zubkova, O. V., Benjes, P. A., and Schramm, V. L. (2004) Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states J. Am. Chem. Soc. 126, 5690-5698 (Pubitemid 38621407)